Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation
Clinical trial NCT02961270 · UNKNOWN
Trial details
- NCT number
- NCT02961270
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.